Single Cell Evaluation in Subsequent-Era Sequencing Market Analysis Report 2022 That includes 10X Genomics, Bio-Rad, Dolomite Bio, Fluidigm, Illumina, Mission Bio,
Analysis

Single Cell Evaluation in Subsequent-Era Sequencing Market Analysis Report 2022 That includes 10X Genomics, Bio-Rad, Dolomite Bio, Fluidigm, Illumina, Mission Bio,

DUBLIN, June 30, 2022 /PRNewswire/ — The “Single Cell Evaluation in Subsequent-Era Sequencing Markets (Market Dimension and Forecast, Section Breakouts, Secondary Analysis), 2022-2027” report has been added to ResearchAndMarkets.com’s providing.

Single Cell Evaluation in Subsequent-Era Sequencing Market Analysis Report 2022 That includes 10X Genomics, Bio-Rad, Dolomite Bio, Fluidigm, Illumina, Mission Bio,

Research_and_Markets_Logo

Single Cell Evaluation in Subsequent-Era Sequencing Markets report focuses available on the market for single cell genomics merchandise – the {hardware}, service of the {hardware}, software program, and consumables together with for the sequencing step and different varieties of downstream evaluation.

It discusses developments, challenges, methods, corporations, and merchandise, and gives estimates of market share and income progress for the market.

The aggressive state of affairs, offers, and merchandise are coated in respective chapters. Historic knowledge for 2021 is supplied, with forecast knowledge spanning 2022-2027.

The report additionally gives essentially the most present market analysis into single cell genomics and the businesses that take part on this market.

A number of the key market developments coated within the report embrace the next:

  • Rising variety of cells profiled

  • Multi-omics focus, merchandise

  • Spatial/in situ genomics, transcriptomics

  • Knowledge evaluation challenges; software program and IT introductions

  • Convergence of technological advances

  • Litigation

Corporations Profiled embrace:

  • 10X Genomics

  • Bio-Rad

  • Dolomite Bio

  • Fluidigm

  • Illumina

  • Mission Bio

  • Qiagen

  • Takara Bio

Key Subjects Coated:

Chapter 1: Government Abstract

  • Single Cell Genomics Income Forecast, Devices/{Hardware} vs. Consumables, 2021-2022 ($M)

  • Single Cell Genomics Market Share, Devices/{Hardware} vs. Consumables, 2021-2022 (%)

  • Scope and Methodology

Chapter 2: Introduction

  • Introduction

  • Purposes

  • Infectious Illness

  • Understanding Most cancers with miRNAs

  • Atherosclerosis Analysis

  • Neurological

  • Market Traits

  • Rising Numbers of Cells Analyzed

  • Important Curiosity in Multi-omics

  • Spatial Transcriptomics, In Situ Methods Gaining Traction

  • Knowledge Evaluation, Knowledge Volumes, Excessive Dimensionality Difficult

  • Convergence of Technological Advances

  • Litigation With Most Main Corporations

  • Offers, Collaborations

Chapter 3: Market Evaluation

  • Revenues Forecast

  • Regional Shares

  • Aggressive Evaluation

  • Merchandise

Chapter 4: Firm Profiles

For extra details about this report go to https://www.researchandmarkets.com/r/drqcf4

Media Contact:
Analysis and Markets
Laura Wooden, Senior Supervisor
press@researchandmarkets.com 
 
For E.S.T Workplace Hours Name +1-917-300-0470
For U.S./CAN Toll Free Name +1-800-526-8630
For GMT Workplace Hours Name +353-1-416-8900
 
U.S. Fax: 646-607-1907
Fax (exterior U.S.): +353-1-481-1716

Emblem: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

Cision

Cision

View authentic content material:https://www.prnewswire.com/news-releases/single-cell-analysis-in-next-generation-sequencing-market-research-report-2022-featuring-10x-genomics-bio-rad-dolomite-bio-fluidigm-illumina-mission-bio-qiagen–takara-bio-301578688.html

SOURCE Analysis and Markets